| Tag | Content |
|---|
EnhancerAtlas ID | HS162-08254 |
Organism | Homo sapiens |
Tissue/cell | Plasma_cell_myeloma |
Coordinate | chr5:55709990-55711910 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nkx2-5(var.2) | MA0503.1 | chr5:55711204-55711215 | CTTGAGTGCTT | - | 6.02 | | SPI1 | MA0080.4 | chr5:55711339-55711353 | GAAAAGAGGAAGCA | + | 6 | | SPIC | MA0687.1 | chr5:55711339-55711353 | GAAAAGAGGAAGCA | + | 6.1 | | SREBF2 | MA0596.1 | chr5:55711278-55711288 | ATCACCCCAT | - | 6.02 | | ZNF263 | MA0528.1 | chr5:55710120-55710141 | TTTTCCCCCTTCTCCTCCCCG | - | 6.01 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_10727 | chr5:55707382-55714321 | CD19_Primary | | SE_11665 | chr5:55705349-55717613 | CD20 | | SE_43491 | chr5:55710778-55713699 | MCF-7 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH05I056411 | chr5 | 55707770 | 55712790 |
|
Enhancer Sequence | AAATGTTCTG CTACTCTGCA GAACTGTTCT TCCCTGCACC CATCTAATTG TGAAATTCTT 60
GCAAGGCTTC AAGTCAGGAA GCATTTCAAA TAGAAAGAGG AACTTTAAAA AATGTGCCCC 120
TGGGGAAAGA TTTTCCCCCT TCTCCTCCCC GAAAAGGACT CATAATTCAT TTCAGCTGCT 180
TTGTATTTTC ATGGCATCAT TTTTTTAAAT AGCAATAGAA AATTGAGACT TTATGGGAGA 240
GGCATCAAAT ATAGGGCTAA ATGTTATTTT GTCTTGGTAA GGCCTAGCAC AGGATTTTAT 300
TAGCTGCTGA TATTTTGTGG GAATCCTGAA ATATCTAAAT TAATTGTCTT CTTTAAACAT 360
TTTTTTTTTT TTCTGAGACA GGGTCTTGCT CTGTCTTCCA AGCTGGAGTG CAGTGGTGTG 420
ATCATGGCTT ACTGCAGCTT TGACCTCCTA GGCTCAGATG ATCCTCTGGC CTCAGTCTCC 480
TGAGTAGCTG GGACCAGAGG CATGCACCAT TACACTCAGC TACATTTTAA AATATTTTTT 540
GTAGAAACAT GTTTTTGCTA TGTTGCCCAG GCTGATTTTG AACTCCTGAG CTAAAGCAAT 600
CCTACCACCT AGGATTTTCA AAGTGCTGGG ATTACAGGCA TGAGCCACTA TGCCACCGCG 660
CCAGTACATG GATCTCTGTA CTTGCCTGGG CAAGGGGGTG AGAATCTGTC TCTACAAAAA 720
AAGTTTTTAA AAATTAGCTG GATGCAGTAG CACACACCTG TAGTTCCAAC TACTCAGGAG 780
GCTGAGGAAG GAGGATCCCT ACAGCCCAGG AGCTCGAGGC TACAGTGAGC TATGATTATG 840
CCACTGCACT CTAGCCTGAG CCACAGAGCA AGACCCTGTT TCTAAAAAAA AAAAAAAGAT 900
ATTGGGGTCA ACCATCACTC CTAGTCTCTC CATGCATGAG AAACTTCACC TCTAATATAA 960
CTCCTTATAG TAGGTTCTCC GACACAAAGT AGTTCTTCAG TAAAGAAAGC CAGTTGCCTT 1020
TGCCCCGTGG CTGTCTCACT ATGGACCTTT GCCGCCTGTG CTATCCGAAA TCCTCTGATG 1080
CTCTTTAGTC ACTCTGGTTT AGCCTCCTGC TATTAAGGCT GACTGTCCCC AAACCCACAG 1140
TAATGAAATA TTGGTCATTA ATATATTGTT AAGTCGTGGC AGCCCCTGCA TCAATATTAA 1200
ATAATTATGG TGTGCTTGAG TGCTTACCAT GTCCTAGGTC GCTGACAGGG TATGATCGAC 1260
CAATAAGACT GAGACAGGAA CTACAGCCAT CACCCCATTT CCCATGACAA ACAGCAGGGC 1320
TCTGAGACTG ATGAAACTTG CCCCCAGGAG AAAAGAGGAA GCAGCAATTG GGCCACGCCT 1380
CTCTACAGAG TTCTTCCAGT TGTTGACTCT AAACTTCTCA CCCCCAAGAA AGTTTCACAG 1440
AGAAGTAGAT TGCACAGTCT TAACACCAGC CTGAGCCTTG GGTCCAGCTT CTTATCTGCA 1500
GTCCAGTCTA CTTCTCAGGA ATGTCTTTCT AGGCCATTGT TTACATTATT TCAAAACCAA 1560
GGAGCTATGA AATTTCTGAG AGTCCTAAGC CTGGAACCTA AAGATTGCAA TTCAAGGCCA 1620
GAATTTGCCT TGTTGTCACT GTCAACTCAC TCTTCTCTTT ATTATCTGCT AGCTTTGAGG 1680
GCTTTTGAAT TCTTAAGACA CATCTTAACT CTTTTCTTGG AGCTTTTAAC ATTTTCAGAT 1740
TTTTAAAAAT AGTTTTGTTC TTTCTTTGTC CTTAGATATC TAGTAATGCT TTCTCAGACT 1800
CGGTCAAGTT AACTCTTCTG GGATTTCATT GTTTTAACTG GCACACTGTG GGAGGTCAGT 1860
GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT GTATGTATAA AACAGACATC 1920
|
